ライフサイエンスコーパス: soy isoflavone

1 ms was evaluated as potential tool to purify soy isoflavones.

2 calcium, vitamin D, protein, potassium, and soy isoflavones.

3 95% CI: 0.53, 0.86; p for trend = 0.001) for soy isoflavones.

4 o, -3.48 ppb [95% CI, -5.99 to -0.97 ppb] vs soy isoflavones, 1.39 ppb [95% CI, -1.73 to 4.51 ppb]) d

5 l Test (placebo, 1.98 [95% CI, 1.42-2.54] vs soy isoflavones, 2.20 [95% CI, 1.53-2.87]; positive valu

6 a control (placebo, 3.3 [95% CI, 2.7-4.1] vs soy isoflavones, 3.0 [95% CI, 2.4-3.7]), and changes in

7 Evidence suggests that soy isoflavones act as estrogen agonists and have benefi

8 genistein, the major bioactive component of soy isoflavones, acts as a radiosensitizer and potentiat

9 ine excretion of glycitein compared to other soy isoflavones after a unique intake of food supplement

10 ether the protective effect of soy is due to soy isoflavones alone or to their combination with other

11 Soy isoflavones, although not as potent as risedronate,

12 The HPLC conditions for soy isoflavone analysis were improved, leading to good s

13 of human intestinal bacterial synthesis from soy isoflavones and also show that both enantiomers are

14 cal studies investigating the combination of soy isoflavones and commonly used chemotherapeutic agent

15 l to evaluate interactive effects of dietary soy isoflavones and estrogen on risk markers for breast

16 In vivo treatment of prostate tumors with soy isoflavones and radiation down-regulated APE1/Ref-1

17 NA-binding activity of NF-kappaB mediated by soy isoflavones and radiation, thus promoting cell killi

18 We compared the in vitro effects of pure soy isoflavones and soy phytochemical concentrate on gro

19 , selenium, fish/marine omega-3 fatty acids, soy, isoflavones and polyphenols; whereas milk, dairy, c

20 ticals such as retinoids, botanicals such as soy isoflavones, and even moisturizers and sunscreen.

21 Soy isoflavones are being evaluated as chemopreventive a

22 Soy isoflavones are naturally occurring phytochemicals w

23 Soy isoflavones are potential cancer chemoprevention tre

24 Soy isoflavones are promising dietary agents for prevent

25 Epidemiological studies implicate dietary soy isoflavones as breast cancer preventives, especially

26 Soy isoflavones attenuated bone loss from the lumbar spi

27 primarily animal protein and one containing soy isoflavones before and after menopause may result in

28 Further, we assessed the effects of dietary soy isoflavones before or after ovariectomy.

29 of this study was to evaluate the effects of soy isoflavones, both in soymilk and in supplement form,

30 of the metabolites of daidzein, a well known soy isoflavone, but its chemopreventive activity and the

31 Our data suggest that soy isoflavones can inhibit bladder tumor growth through

32 ether components of soy products or purified soy isoflavones can inhibit the progression of bladder c

33 bo-controlled trial to examine the effect of soy isoflavone capsules (80 mg/d of total isoflavones, 5

34 bjective of this study is thus to identify a soy isoflavone combination with lower levels of daidzein

35 For treatment with soy isoflavone combination, genistein was always better

36 ic compounds and eleven bound phenolics in a soy isoflavone concentrate.

37 ty, and both of which were down-regulated by soy isoflavones, confirming the cross-talk between these

38 The present study examined the effects of soy isoflavone consumption on plasma concentrations of t

39 The effects of soy isoflavone consumption on plasma total cholesterol,

40 We describe the effects of soy isoflavone consumption on prostate specific antigen

41 ng-term effect of dietary soy protein and/or soy isoflavone consumption on skeletal health in late po

42 Development of a database of the soy isoflavone content of foods requires accurate and pr

43 rotein with normal (OVX+SOY) or reduced (OVX+SOY-) isoflavone content for 65 days.

44 The soy isoflavone daidzein is metabolized to equol and O-de

45 sively synthesize S-equol from the precursor soy isoflavone daidzein, and it is significant that, unl

46 sly reported that equol, a metabolite of the soy isoflavone daidzein, may advance breast cancer poten

47 ers contrasts with previous findings for the soy isoflavones daidzein and genistein, both of which ha

48 Equol, unlike the soy isoflavones daidzein or genistein, has a chiral cent

49 recovery, we discovered that an FDA-approved soy isoflavone, daidzein, improved stroke-induced behavi

50 Soy isoflavones decreased APE1/Ref-1 expression in vitro

51 These data suggest that short-term intake of soy isoflavones did not affect serum hormone levels, tot

52 Soy isoflavones did not significantly affect calcium met

53 lly the concern for consumers taking regular soy isoflavone dietary supplements.

54 igh levels of phytoestrogens, in the form of soy isoflavones, during a stage of development at which

55 not show a bone-sparing effect of extracted soy isoflavones, except for a modest effect at the femor

56 Soy isoflavones exhibit a number of biological effects,

57 ontrolled intervention with a genistein-rich soy isoflavone extract (10mg/kg/day of genistein) follow

58 oflavone extracts and results were mixed for soy isoflavone extracts.

59 Pretreatment with soy isoflavones followed by radiation inhibited APE1/Ref

60 The soy isoflavone genistein and the benzoquinonoid antibiot

61 The soy isoflavone genistein attenuates growth factor- and c

62 Soy isoflavone genistein exhibits growth inhibitory acti

63 The soy isoflavones genistein and daidzein are found in bloo

64 cause of potential estrogenic effects of the soy isoflavones genistein and daidzein.

65 The molecular mechanisms by which soy isoflavones (genistein, daidzein, and equol) afford

66 monstrated that dietary daidzein or combined soy isoflavones (genistein, daidzein, and glycitein) inc

67 Pure soy isoflavones (genistein, genistin, daidzein, and bioc

68 We investigated interactions between the soy isoflavone, genistein, and an antiestrogen, tamoxife

69 and 0.01 L (95% CI, -0.07 to 0.07 L) in the soy isoflavone group, which were not significantly diffe

70 s consisted of a placebo control group and 2 soy isoflavone groups (80 compared with 120 mg/d); women

71 cts receiving a daily supplement with 120 mg soy isoflavones had a statistically significant smaller

72 component of dietary fiber, total fruit, and soy isoflavones had the strongest associations.

73 cant interest in the mechanisms of action of soy isoflavones has predominantly stemmed from in vitro

74 Although genistein, a soy isoflavone, has beneficial effects on various tissue

75 Soy isoflavones have antiestrogenic and anticancer prope

76 Soy isoflavones have antioxidant properties in vitro, bu

77 ne expression, and reduced blood pressure by soy isoflavones have implications for alternative therap

78 Soy isoflavones have numerous biological properties that

79 Soy isoflavones have variable effects on the prevention

80 changes following dietary intervention with soy isoflavones in healthy premenopausal women under con

81 drawn to the safety of using high levels of soy isoflavones in humans, which is especially the conce

82 ic effect, thereby providing a novel role of soy isoflavones in the regulation of insulin secretion.

83 been attributed to high soy diets, and major soy isoflavones, in particular daidzein and genistein, a

84 Soy isoflavones induce a G2-M cell cycle arrest in all h

85 Soy isoflavone intake (mg/d) was measured with validated

86 To study the relation between soy isoflavone intake and bone mineral density (BMD), th

87 Despite large differences in soy isoflavone intake by country, isoflavone consumption

88 intake, as measured by either soy protein or soy isoflavone intake, was inversely associated with mor

89 Three soy isoflavone intakes (control: 10.0 +/- 1.1; low: 64.7

90 Daidzein, a soy isoflavone, is a clinically approved agent that has

91 Some data suggest that supplementation with soy isoflavone may be an effective treatment for patient

92 However, soy isoflavones may also have a role in promoting breast

93 presence of estrogen higher doses of dietary soy isoflavones may alter ER signaling and induce select

94 Potential mechanisms by which soy isoflavones might prevent atherosclerosis include a

95 de metastasis, which was not observed with a soy isoflavone mixture consisting of genistein, daidzein

96 licting results with regard to the effect of soy isoflavones on breast cancer risk.

97 m was to investigate the effects of isolated soy isoflavones on inflammatory biomarkers [von Willebra

98 e was to investigate the effects of isolated soy isoflavones on metabolic biomarkers of cardiovascula

99 Interventions were 5 soy isoflavone oral supplements (2 doses of a genistein-

100 have been studied as receptors activated by soy isoflavones, perhaps explaining the lipid-lowering e

101 ctive of this study was to determine whether soy isoflavone phase II metabolism differs between human

102 The soy isoflavone phytoestrogens, genistein and daidzein, a

103 determine the molecular mechanisms by which soy isoflavones potentiate radiotherapy, we investigated

104 Gut bacterial modification of soy isoflavones produces metabolites that differ in biol

105 rticipants were randomly assigned to receive soy isoflavone supplement containing 100 mg of total iso

106 did not significantly improve more with the soy isoflavone supplement than with placebo.

107 ile taking a controller medication, use of a soy isoflavone supplement, compared with placebo, did no

108 o and after control for pretreatment values, soy isoflavone supplementation had no effect on arginine

109 When compared with the placebo, soy isoflavone supplementation had no effect on changes

110 o protect against bone loss, the efficacy of soy isoflavone supplementation in the prevention of oste

111 Our aim was to test the effect of soy isoflavone supplementation on bone health.

112 The objective was to test the effect of soy isoflavone supplementation on nitric oxide productio

113 The efficacy of soy isoflavone supplementation to stimulate nitric oxide

114 Soy isoflavone supplements are used to treat several chr

115 Use of soy-based infant formulas and soy/isoflavone supplements has aroused concern because o

116 Genistein is a soy isoflavone that has antitumor activity both in vitro

117 Bacterial metabolism of soy isoflavones varies among individuals.

118 on, while no consistent increase of the four soy isoflavones was determined.

119 terventions such as dietary and supplemental soy isoflavones were associated with improvement in dail

120 laboratory and animal studies reported that soy isoflavones were major bioactive compounds in soy to

121 human equivalent of 0, 60, 120, or 240 mg/d soy isoflavones with a dose of oral micronized 17beta-es

122 In an orthotopic model, combining soy isoflavones with tumor irradiation inhibited prostat